Classic Hodgkin lymphoma: Pathobiological features that impact emerging therapies
{{output}}
Classic Hodgkin lymphoma (cHL) is defined by distinctive Hodgkin Reed-Sternberg (HRS) cells, which are CD30+/CD15+ multinucleated tumor cells lacking typical B-cell markers. These cells comprise
